Angiotensin II: a new approach for refractory shock management? - Wikidata - wikimedia - TriplyDB

Angiotensin II: a new approach for refractory shock management?

Angiotensin II: a new approach for refractory shock management?

http://www.wikidata.org/entity/Q35090438

about

Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?The use of angiotensin II in distributive shock

P2860

Q42341974-852B89F0-34EA-443A-AA80-A8236327CD68 Q42756954-9BAB0284-C930-40CC-AFAA-BBE4464CBAE3

P2860

Angiotensin II: a new approach for refractory shock management?

http://www.wikidata.org/entity/Q35090438

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Angiotensin II: a new approach for refractory shock management?

@ast

Angiotensin II: a new approach for refractory shock management?

@en

type

label

Angiotensin II: a new approach for refractory shock management?

@ast

Angiotensin II: a new approach for refractory shock management?

@en

prefLabel

Angiotensin II: a new approach for refractory shock management?

@ast

Angiotensin II: a new approach for refractory shock management?

@en

P1433

Q35090438-3989D9BE-7E04-4D63-A064-34ACEEC1DDEA

P1476

Q35090438-08FB3607-4593-426D-9290-95AD4DE8CE9C

P2093

Q35090438-B0F50DBA-4424-4F4F-B227-ED444B4EF3F8

Q35090438-E78FA847-906C-4F5A-9061-1552AB0F6F91

P2860

Q35090438-123B8FFA-205E-43BA-AE2C-BFE8299B0D2A

Q35090438-19D139E1-5CD2-4D51-A02B-4FF89CDF2377

Q35090438-3E605A1B-52B6-4800-9AA7-B707EF3899D4

Q35090438-46AAABAE-A252-467C-B089-E8F566268019

Q35090438-6338FECF-00F2-48EF-866D-D00BDE8F91FE

Q35090438-6685D1E5-D1E6-4DD3-8705-5B3BBB0596D8

Q35090438-9E5A4976-C19C-4E1F-B21B-286119ED0AB7

Q35090438-A1FF8304-B1E8-44EC-8960-E2A726B100DE

Q35090438-AE08B941-0927-4091-9274-490361677ADE

Q35090438-B42ABDD5-CE3F-4963-9E4B-7CB72FAEACE7

P2888

Q35090438-50284144-96FE-4A11-B0CE-83CD6596E234

P304

Q35090438-7F9DE05C-3969-49D0-A5DE-5597A6BB49D8

P31

Q35090438-2A7CAEEE-D801-4FFC-A037-826F32B09E69

P356

Q35090438-5822F367-C034-404B-93E8-1386050E024E

P433

Q35090438-9179DE45-5B36-4B06-83E3-57DF9D7D3770

P478

Q35090438-AF8253E6-1DC7-4ED8-BEF7-0F3B194522E5

P577

Q35090438-72D46C6B-2F13-4385-9BFE-21273BC87B48

P5875

Q35090438-48578F40-4044-48F2-A197-58E9704546F6

P6179

Q35090438-ABF74B53-7A25-4293-BD73-04227C7FD6A9

P698

Q35090438-5765170D-1EAF-4E5F-853E-74E8AD203B97

P932

Q35090438-B3C36168-966E-41E3-BEBA-F69FC2828A58

P356

S13054-014-0694-7

P1433

P1476

Angiotensin II: a new approach for refractory shock management?

@en

P2093

Antoine Kimmoun

http://www.w3.org/2001/XMLSchema#string

Bruno Levy

http://www.w3.org/2001/XMLSchema#string

P2860

The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension.

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Early management of severe sepsis: concepts and controversies.

Vasopressin versus norepinephrine infusion in patients with septic shock.

The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.

Refractory septic shock: efficacy and safety of very high doses of norepinephrine.

Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats.

Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.

P2888

s13054-014-0694-7

P304

694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13054-014-0694-7

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272083923

http://www.w3.org/2001/XMLSchema#string

P6179

1017080802

http://www.w3.org/2001/XMLSchema#string

P698

25645552

http://www.w3.org/2001/XMLSchema#string

P932

4330931

http://www.w3.org/2001/XMLSchema#string